Somatostatin is a neuropeptide which is produced in neuroendocrine cells of the brain, thyroid, pancreas, and GI tract. Within these tissues somatostatin appears to act in a paracrine fashion to inhibit the release of various hormones including growth hormone, calcitonin, insulin, glucagon, and gastrin. Somatostatin biosynthesis and secretion are regulated by agents which stimulate adenyl cyclase activity. The overall objectives of this study are to elucidate the mechanisms underlying the cAMP-regulated and tissue-specific expression of the rat somatostatin gene. Experiments on cAMP-responsiveness will focus on two specific aims: (1) To determine, by Exonuclease III protection experiments, whether the cAMP-responsive element in the rat somatostatin gene binds to non-histone proteins in chromatin and nuclear extracts of cAMP-treated cells; (2) To determine whether cAMP-stimulated somatostation secretion and gene transcription are regulated by different cAMP-dependent protein kinases. These experiments will be performed by comparing secretion and transcription in transfected neuroendocrine (PC12) cell lines which are deficient in either cAMP-dependent protein kinase type 1 or type 2. The mechanisms by which cAMP-regulates peptide hormones like somatostatin may be particularly useful in obtaining an understanding of the pathophysiology of such endocrine-metabolic diseases as diabetes mellitus. Experiments on tissue-specific expression of the somatostatin gene are designed to meet the following specific aims: (3) To characterize the sequences required for cell-specific expression of the somatostatin gene in a medullary thyroid carinoma cell line by transfection of a promoter deletion series of somatostatin fusion genes containing the bacterial reporter gene chloramphenicol acetyl transferase (CAT). (4) To characterize sequences within the somatostatin gene which bind non-histone proteins in chomatin and nuclear extracts of somatostatin-producing medullary thyroid carcinoma cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM037828-03
Application #
3293609
Study Section
Biochemistry Study Section (BIO)
Project Start
1986-12-01
Project End
1989-11-30
Budget Start
1988-12-01
Budget End
1989-11-30
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Salk Institute for Biological Studies
Department
Type
DUNS #
005436803
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Dentin, Renaud; Hedrick, Susan; Xie, Jianxin et al. (2008) Hepatic glucose sensing via the CREB coactivator CRTC2. Science 319:1402-5
Ravnskjaer, Kim; Kester, Henri; Liu, Yi et al. (2007) Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression. EMBO J 26:2880-9
Mayr, Bernhard M; Guzman, Ernesto; Montminy, Marc (2005) Glutamine rich and basic region/leucine zipper (bZIP) domains stabilize cAMP-response element-binding protein (CREB) binding to chromatin. J Biol Chem 280:15103-10
Shaw, Reuben J; Lamia, Katja A; Vasquez, Debbie et al. (2005) The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310:1642-6
Zhang, Xinmin; Odom, Duncan T; Koo, Seung-Hoi et al. (2005) Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci U S A 102:4459-64
Canettieri, Gianluca; Koo, Seung-Hoi; Berdeaux, Rebecca et al. (2005) Dual role of the coactivator TORC2 in modulating hepatic glucose output and insulin signaling. Cell Metab 2:331-8
Best, Jennifer L; Amezcua, Carlos A; Mayr, Bernhard et al. (2004) Identification of small-molecule antagonists that inhibit an activator: coactivator interaction. Proc Natl Acad Sci U S A 101:17622-7
Koo, Seung-Hoi; Satoh, Hiroaki; Herzig, Stephan et al. (2004) PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. Nat Med 10:530-4
Conkright, Michael D; Canettieri, Gianluca; Screaton, Robert et al. (2003) TORCs: transducers of regulated CREB activity. Mol Cell 12:413-23
Jhala, Ulupi S; Canettieri, Gianluca; Screaton, Robert A et al. (2003) cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev 17:1575-80

Showing the most recent 10 out of 41 publications